{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:49:45Z","timestamp":1790430585614,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Se 529\/5-2"],"award-info":[{"award-number":["Se 529\/5-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.pharmthera.2013.07.002","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T12:17:32Z","timestamp":1373372252000},"page":"200-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Inhibitors of Bacillus anthracis edema factor"],"prefix":"10.1016","volume":"140","author":[{"given":"Roland","family":"Seifert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Dove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2013.07.002_bb0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/10408410490468795","article-title":"The adenylate cyclase toxins","volume":"30","author":"Ahuja","year":"2004","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0010","first-page":"5","article-title":"Forskolin and derivatives as tools for studying the role of cAMP","volume":"67","author":"Alasbahi","year":"2012","journal-title":"Pharmazie"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0015","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0003-2697(90)90423-7","article-title":"A single column method for the assay of adenylate cyclase","volume":"187","author":"Alvarez","year":"1990","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0020","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0025","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.mam.2009.08.004","article-title":"Anthrax in animals","volume":"30","author":"Beyer","year":"2009","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0365","doi-asserted-by":"crossref","first-page":"e68009","DOI":"10.1371\/journal.pone.0068009","article-title":"Similarly potent inhibition of adenylyl cyclase by P-site inhibitors in hearts from wild-type and AC5 knockout mice","volume":"8","author":"Br\u00e4unig","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0040","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.bmc.2011.10.091","article-title":"Structure-based redesign of an edema toxin inhibitor","volume":"20","author":"Chen","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0035","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.1016\/j.bmc.2008.06.036","article-title":"Novel inhibitors of anthrax edema factor","volume":"16","author":"Chen","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0045","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.1074\/jbc.M110.166868","article-title":"Multidrug resistance protein 4 (MRP4\/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation","volume":"286","author":"Copsel","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0050","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1742-1241.2004.00364.x","article-title":"Adefovir dipivoxil: review of a novel acyclic nucleoside analogue","volume":"58","author":"Danta","year":"2004","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/bsp.2011.0104","article-title":"A decade of countering bioterrorism: incremental progress, fundamental failings","volume":"10","author":"Danzig","year":"2012","journal-title":"Biosecur Bioterror"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0060","doi-asserted-by":"crossref","first-page":"F400","DOI":"10.1152\/ajprenal.2000.279.3.F400","article-title":"Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase","volume":"279","author":"Defer","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-3-540-68964-5_2","article-title":"Biochemistry of soluble guanylate cyclase","volume":"191","author":"Derbyshire","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-6147(99)01310-3","article-title":"The interactions of adenylate cyclase with P-site inhibitors","volume":"20","author":"Dessauer","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0075","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MNH.0b013e3283621510","article-title":"Osmoregulation, vasopressin, and cAMP signaling in autosomal dominant polycystic kidney disease","volume":"22","author":"Devuyst","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0080","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jiph.2010.07.004","article-title":"A review of cutaneous anthrax and its outcome","volume":"3","author":"Doganay","year":"2010","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0085","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.bcp.2011.07.099","article-title":"Impact of divalent metal ions on regulation of adenylyl cyclase isoforms by forskolin analogs","volume":"82","author":"Erdorf","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0090","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1124\/jpet.110.174219","article-title":"Bis-halogen-anthraniloyl-substituted nucleoside 5\u2032-triphosphates as potent and selective inhibitors of Bordetella pertussis adenylyl cyclase toxin","volume":"336","author":"Geduhn","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0095","doi-asserted-by":"crossref","first-page":"19955","DOI":"10.1074\/jbc.M312560200","article-title":"Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides","volume":"279","author":"Gille","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0110","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1021\/bi100684g","article-title":"Cytidylyl and uridylyl cyclase activity of Bacillus anthracis edema factor and Bordetella pertussis CyaA","volume":"49","author":"G\u00f6ttle","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0100","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1124\/mol.107.034413","article-title":"Molecular analysis of the interaction of Bordetella pertussis adenylyl cyclase with fluorescent nucleotides","volume":"75","author":"G\u00f6ttle","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0105","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1124\/jpet.109.150953","article-title":"Characterization of mouse heart adenylyl cyclase","volume":"329","author":"G\u00f6ttle","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0115","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1038\/sj.emboj.7600800","article-title":"Structural basis for the interaction of Bordetella pertussis adenylyl cyclase toxin with calmodulin","volume":"24","author":"Guo","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0120","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3390\/toxins3091185","article-title":"The potential contributions of lethal and edema toxins to the pathogenesis of anthrax associated shock","volume":"3","author":"Hicks","year":"2011","journal-title":"Toxins"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0125","doi-asserted-by":"crossref","first-page":"H1108","DOI":"10.1152\/ajpheart.01128.2010","article-title":"Anthrax edema toxin has cAMP-mediated stimulatory effects and high-dose lethal toxin has depressant effects in an isolated perfused rat heart model","volume":"300","author":"Hicks","year":"2011","journal-title":"Am J Physiol Circ Physiol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0130","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/s00134-012-2541-0","article-title":"An overview of anthrax infection including the recently identified form of disease in injection drug users","volume":"38","author":"Hicks","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/mol.111.071894","article-title":"Structural basis for the high-affinity inhibition of mammalian membranous adenylyl cyclase by 2\u2032,3\u2032-O-(N-methylanthraniloyl)-inosine 5\u2032-triphosphate","volume":"80","author":"H\u00fcbner","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0135","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00210-011-0626-x","article-title":"Effect of MANT-nucleotides on L-type calcium currents in murine cardiomyocytes","volume":"383","author":"H\u00fcbner","year":"2011","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0145","doi-asserted-by":"crossref","first-page":"H2622","DOI":"10.1152\/ajpheart.00190.2012","article-title":"Prevention of heart failure in mice by an antiviral agent that inhibits type 5 cardiac adenylyl cyclase","volume":"302","author":"Iwatsubo","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0150","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0076-6879(97)78020-0","article-title":"Fluorescent nucleotide analogs: synthesis and applications","volume":"278","author":"Jameson","year":"1997","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0155","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0140-6736(10)61265-2","article-title":"Continuing challenge of infectious diseases in India","volume":"377","author":"John","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0160","doi-asserted-by":"crossref","first-page":"19035","DOI":"10.1016\/S0021-9258(17)30620-8","article-title":"Inhibition of Bordetella pertussis and Bacillus anthracis adenylyl cyclases by polyadenylate and \u201cP\u201d-site agonists","volume":"265","author":"Johnson","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0165","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1517\/14712590903307347","article-title":"Anthrax prevention and therapy treatment: utility of therapy combining antibiotic plus vaccine","volume":"9","author":"Klinman","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0170","doi-asserted-by":"crossref","first-page":"11277","DOI":"10.1073\/pnas.0914611107","article-title":"Use of allostery to identify inhibitors of calmodulin-induced activation of Bacillus anthracis edema factor","volume":"107","author":"Laine","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0175","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.chembiol.2004.05.020","article-title":"Discovery of a small molecule that inhibits the interaction of anthrax edema factor with its cellular activator, calmodulin","volume":"11","author":"Lee","year":"2004","journal-title":"Chem Biol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0370","doi-asserted-by":"crossref","first-page":"H238","DOI":"10.1152\/ajpheart.00185.2013","article-title":"B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine stimulated contraction in a rat aortic ring model","volume":"305","author":"Li","year":"2013","journal-title":"Am J Physiol Haert Physiol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0185","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.RES.0000102042.83024.CA","article-title":"What is the role of \u03b2-adrenergic signaling in heart failure?","volume":"93","author":"Lohse","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0190","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/AOG.0b013e318270ec08","article-title":"Anthrax cases in pregnant and postpartum women: a systematic review","volume":"120","author":"Meaney-Delman","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0195","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.cellsig.2010.11.018","article-title":"Cyclic AMP-mediated immune regulation \u2014 overview of mechanisms of action in T cells","volume":"23","author":"Mosenden","year":"2011","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0200","first-page":"303","article-title":"ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins","volume":"61","author":"Moss","year":"1988","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0205","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1074\/jbc.M409076200","article-title":"Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2\u2032(3\u2032)-O-(N-methylanthraniloyl)-guanosine 5\u2032-triphosphate","volume":"280","author":"Mou","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0210","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1124\/mol.106.026427","article-title":"Broad specificity of mammalian adenylyl cyclase for interaction with 2\u2032,3\u2032-substituted purine- and pyrimidine nucleotide inhibitors","volume":"70","author":"Mou","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0215","doi-asserted-by":"crossref","first-page":"pe37","DOI":"10.1126\/scisignal.275pe37","article-title":"Putting on the brakes: cyclic AMP as a multipronged controller of macrophage function","volume":"2","author":"Peters-Golden","year":"2009","journal-title":"Sci Signal"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0220","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.bcp.2011.05.010","article-title":"Structure\u2013activity relationships for the interactions of 2\u2032- and 3\u2032-(O)-(N-methyl)anthraniloyl-substituted purine and pyrimidine nucleotides with mammalian adenylyl cyclases","volume":"82","author":"Pinto","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrm2082","article-title":"Capturing cyclic nucleotides in action: snapshots from crystallographic studies","volume":"8","author":"Rehmann","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0230","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1139\/o83-118","article-title":"Pharmacological antagonism of calmodulin","volume":"61","author":"Roufogalis","year":"1983","journal-title":"Can J Biochem Cell Biol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0235","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tips.2008.01.006","article-title":"Multidrug resistance protein 4 (MRP4\/ABCC4): a versatile efflux transporter for drugs and signalling molecules","volume":"29","author":"Russel","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0240","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/bsp.2012.0305","article-title":"U.S. medical countermeasure development since 2001: a long way yet to go","volume":"10","author":"Russell","year":"2012","journal-title":"Biosecur Bioterror"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0245","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000166277","article-title":"Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies","volume":"15","author":"Sadana","year":"2009","journal-title":"Neurosignals"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0250","doi-asserted-by":"crossref","first-page":"18902","DOI":"10.1016\/S0021-9258(17)30601-4","article-title":"Binding of 3\u2032-anthraniloyl-2\u2032-deoxy-ATP to calmodulin-activated adenylate cyclase from Bordetella pertussis and Bacillus anthracis","volume":"265","author":"Sarfati","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0255","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3390\/toxins4111288","article-title":"Pharmacophore selection and redesign of non-nucleotides inhibitors of anthrax edema factor","volume":"4","author":"Schein","year":"2012","journal-title":"Toxins"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0260","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0163-7258(00)00051-6","article-title":"Cyclic nucleotide analogs as biochemical tools and prospective drugs","volume":"87","author":"Schwede","year":"2000","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0265","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.tim.2012.04.002","article-title":"Towards selective inhibitors of adenylyl cyclase toxin from Bordetella pertussis","volume":"20","author":"Seifert","year":"2012","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0270","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tips.2011.10.006","article-title":"Inhibitors of membranous adenylyl cyclases","volume":"33","author":"Seifert","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0275","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1093\/emboj\/cdf681","article-title":"Physiological calcium concentrations regulate calmodulin binding and catalysis of adenylyl cyclase exotoxins","volume":"21","author":"Shen","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0285","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/sj.emboj.7600574","article-title":"Calcium-independent calmodulin binding and two-metal-ion catalytic mechanism of anthrax edema factor","volume":"24","author":"Shen","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0280","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1073\/pnas.0306552101","article-title":"Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection","volume":"101","author":"Shen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0290","doi-asserted-by":"crossref","first-page":"34742","DOI":"10.1074\/jbc.274.49.34742","article-title":"Inhibition of adenylyl cyclase by acyclic nucleoside phosphonate antiviral agents","volume":"274","author":"Shoshani","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0295","doi-asserted-by":"crossref","first-page":"25990","DOI":"10.1074\/jbc.M301232200","article-title":"Structure-based inhibitor discovery against adenylyl cyclase toxins from pathogenic bacteria that cause anthrax and whooping cough","volume":"278","author":"Soelaiman","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0300","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ab.2008.06.014","article-title":"A fluorometric assay for real-time monitoring of adenylyl cyclase activity based on terbium norfloxacin","volume":"381","author":"Spangler","year":"2008","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0305","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1124\/mi.2.3.168","article-title":"Isoforms of mammalian adenylyl cyclase: multiplicities of signaling","volume":"2","author":"Sunahara","year":"2002","journal-title":"Mol Interv"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0310","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bcp.2009.04.006","article-title":"Distinct interactions of 2\u2032- and 3\u2032-O-(N-methyl)anthraniloyl-isomers of ATP and GTP with the adenylyl cyclase toxin of Bacillus anthracis, edema factor","volume":"78","author":"Suryanarayana","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0315","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1164\/rccm.201102-0209CI","article-title":"Anthrax infection","volume":"184","author":"Sweeney","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0325","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00210-011-0688-9","article-title":"Inhibition of the adenylyl cyclase toxin, edema factor, from Bacillus anthracis, by a series of 18 mono- and bis-(M)ANT-substituted nucleoside 5\u2032-triphosphates","volume":"385","author":"Taha","year":"2012","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0320","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1124\/mol.108.052340","article-title":"Molecular analysis of the interaction of anthrax adenylyl cyclase toxin, edema factor, with 2\u2032(3\u2032)-O-(N-methyl)anthraniloyl)-substituted purine and pyrimidine nucleotides","volume":"75","author":"Taha","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0330","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.mam.2009.06.001","article-title":"The adenylyl cyclase activity of anthrax edema factor","volume":"30","author":"Tang","year":"2009","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0335","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbapap.2007.10.002","article-title":"Signaling through cAMP and cAMP-dependent protein kinase: diverse strategies for drug design","volume":"1784","author":"Taylor","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0340","doi-asserted-by":"crossref","first-page":"14464","DOI":"10.1021\/bi0015562","article-title":"Molecular basis for P-site inhibition of adenylyl cyclase","volume":"39","author":"Tesmer","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0345","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/ki.2011.95","article-title":"Intracellular cAMP signalling by soluble adenylyl cyclase","volume":"79","author":"Tresguerres","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0350","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1517\/14740338.2011.593507","article-title":"Drug safety evaluation of adefovir in HBV infection","volume":"10","author":"Vigan\u00f2","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0355","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mib.2005.12.011","article-title":"Bordetella adenylate cyclase toxin: a swift saboteur of host defense","volume":"9","author":"Vojtova","year":"2006","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.pharmthera.2013.07.002_bb0360","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/0022-3859.101396","article-title":"Forskolin, upcoming antigaucoma molecule","volume":"58","author":"Wagh","year":"2012","journal-title":"J Postgrad Med"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725813001484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725813001484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:51:46Z","timestamp":1759009906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725813001484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0163725813001484"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2013.07.002","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitors of Bacillus anthracis edema factor","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2013.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}